HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Dunger-Baldauf Selected Research

DNK 333

6/2011Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Dunger-Baldauf Research Topics

Disease

2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2011 - 12/2005
1Abdominal Pain (Pain, Abdominal)
06/2011
1Pain (Aches)
12/2005
1Constipation
12/2005

Drug/Important Bio-Agent (IBA)

1DNK 333IBA
06/2011
1tegaserod (Zelnorm)FDA Link
12/2005

Therapy/Procedure

1Therapeutics
12/2005